CDLX Valuation

Cardlytics Inc

Add to Watchlist

Advanced Chart

2.705

-0.415(-13.301%)1D

Overview
Forecast
Valuation
Earnings

CDLX Relative Valuation

CDLX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CDLX is overvalued; if below, it's undervalued.

Historical Valuation

Cardlytics Inc (CDLX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of -25.61. The fair price of Cardlytics Inc (CDLX) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 3.12 USD , Cardlytics Inc is Undervalued By Fair.

Relative Value

Fair Zone

+Inf-+Inf

Current Price：3.12

Fair

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.54

P/B

Median3y

1.57

Median5y

4.52

0.65

FCF Yield

Median3y

-10.23

Median5y

-6.73

Competitors Valuation Multiple

The average P/S ratio for CDLX's competitors is 1.44, providing a benchmark for relative valuation. Cardlytics Inc Corp (CDLX) exhibits a P/S ratio of 0.60, which is -58.55% above the industry average. Given its robust revenue growth of -8.45%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap